東 北 虎 藥 業 股 份 有 限 公 司

NORTHEAST TIGER PHARMACEUTICAL CO., LTD.*

(A joint stock limited company incorporated in the People's Republic of China)

(Stock Code: 8197)

PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING

I/We (note 1)

of

am/are the registered holder(s) of (note 2)

Shares in Northeas t Ti ge r P h ar m aceuti cal Co., Ltd (the "Company"), HEREBY APPOINT (note 3)

of if he/she could not attend, then appoint (note 3)

of if he/she could not attend, then appoint the Chairman of the Annual General Meeting as my/our proxy(ies) of (note 4) Shares of the Company to attend the Annual General Meeting of the Company to be held at No.3,No.2 Road, Jilin Hi-Tech Development Zone, Jilin City, Jilin Province, the People's Republic of China at 9:00 a.m. on 29 May 2014 or at any adjournment thereof, and to exercise the right of voting in such meeting in respect of the resolutions as hereunder indicated, or if no such indication is given, as my/our proxy(ies) think(s) fit.

RESOLUTIONS

For(note5)

Against(note 5)

1.

To receive and consider the audited financial statements of the Company and the Report of the Directors and the Auditors

respectively for the year ended 31 December 2013;

2.

To appoint auditors and to authorize the board of directors of the Company to fix their remuneration;

3.

To empower the executive directors of the Company to exercise the authority for the determination of incentive bonus to the

relevant person of the Company as a motivation for the contribution of efforts to the development of the Company, if any;

4.

To consider and approve the remuneration proposals for Directors and supervisors of the Company for the year ending 31

December 2013;

5.

To grant to the Board an unconditional general mandate to allot, issue and deal with new domestic shares ("Domestic Shares")

and overseas listed foreign shares ("H Shares"); and

6.

To consider and elect the appointment of Mr. Liu Yang as executive directors of the Board of Directors (his biographical details

are set out in Appendix 1 herein) due to expiry of his terms of office and he shall be eligible for re-election by shareholders upon the end of the term according to the articles of association of the Company;

7.

To consider and elect the appointment of Madam Guo Feng as executive directors of the Board of Directors (his biographical

details are set out in Appendix 1 herein) due to expiry of his terms of office and he shall be eligible for re-election by shareholders upon the end of the term according to the articles of association of the Company;

8.

To consider and elect the appointment of Mr. Qin Haibo as executive directors of the Board of Directors (his biographical

details are set out in Appendix 1 herein) due to expiry of his terms of office and he shall be eligible for re-election by shareholders upon the end of the term according to the articles of association of the Company;

9.

To consider and elect the appointment of Mr. Lam Kai Yeung as executive directors of the Board of Directors (his biographical

details are set out in Appendix 1 herein) due to expiry of his terms of office and he shall be eligible for re-election by shareholders upon the end of the term according to the articles of association of the Company;

10.

To consider and elect the appointment of Madam Niu Shu Min as executive directors of the Board of Directors (his

biographical details are set out in Appendix 1 herein) due to expiry of his terms of office and he shall be eligible for re-election by shareholders upon the end of the term according to the articles of association of the Company;

11.

To consider and elect the appointment of Mr. Zhao Zhen Xing as executive directors of the Board of Directors (his biographical

details are set out in Appendix 1 herein) due to expiry of his terms of office and he shall be eligible for re-election by shareholders upon the end of the term according to the articles of association of the Company; and

12.

To transact any other business, if any.

Date: Signature(s):

Notes:

1. Please insert the full name(s) and address(es) as shown in the register of member(s) in BLOCK LETTERS.
2. Please insert the number and class of shares registered in your name(s) and those related to this proxy form.
3. Please insert the full name and address of the person to be appointed as proxy. If you do not insert the name and address of the person to be appointed as your proxy in the space provided, the Chairman of the Annual General Meeting will be your proxy.
4. If no number is inserted, this proxy form will be deemed to be related to all the shares of the Company registered in your name(s).
5. IMPORTANT: IF YOU WISH TO VOTE FOR ANY RESOLUTION, PLEASE TICK THE BOX MARKED "FOR". If no such indication is given, the proxy will be entitled to cast your vote at his discretion.
6. This form of proxy must be signed by you or your attorney duly authorized in writing or, in the case of a legal person or body corporate, must be either executed under its common seal or under the hand of a director of the legal person or body corporate or proxy duly authorized in writing.
7. To be valid, this form of proxy (or if it is signed by his attorney duly authorized in writing, then together with such power of attorney or other authority under which it is signed or a notarially certified copy of such power of attorney or authority) must be deposited not later than 24 hours before the specified time for holding the meeting, in respect of H Shares, at the Company's Registrar of H Shares - Computershare Hong Kong Investor Services Limited, 46th Floor, Hopewell Centre, 183 Queen's Road East, Hong Kong.

* For identification purpose only

distributed by